Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy
Clinical trial NCT05512130 · UNKNOWN
Trial details
- NCT number
- NCT05512130
- Sponsor
- Washington University School of Medicine
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-17
- Primary completion
- 2023-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.